Abstract
Objective: To compare trough and peak serum gentamicin concentrations in neonatal patients using two dosing regimens.
Method: A retrospective audit of gentamicin serum concentrations obtained with the current neonatal gentamicin‐dosing regimen (regimen 1) was conducted. Results were then compared with the introduction of a new regimen (regimen 2). Preliminary results necessitated a change to a further dosage schedule (regimen 3), where data was again collected.
Results: For regimen 1,79% of patients achieved satisfactory trough concentrations, 30% achieved satisfactory peak concentrations, and 16% achieved a satisfactory combined trough and peak concentration.For regimen 2,80% of patients achieved satisfactory trough concentrations, 63% achieved satisfactory peak concentrations, and 48% achieved a satisfactory combined trough and peak concentration.For regimen 3,76% of patients achieved satisfactory trough concentrations, 56% achieved satisfactory peak concentrations, and 45% achieved a satisfactory combined trough and peak concentration.
Conclusion: Regimen 3 shows a marked improvement in serum gentamicin concentrations. However neonates in the 32‐38 weeks post‐conceptional age group achieved higher trough and peak serum gentamicin levels than expected. Therefore the dosage interval in this group of neonates will be increased from 18 hourly to 24 hourly dosing, and regimen reaudited.
References
McCormack JP, Jewesson PJ. A critical re-evaluation of the 'therapeutic range' of aminoglycosides. Clin Infect Dis 1992;14:320-39.
Thomson AH, Way S, Bryson SM, McGovern EM, Kelmann AW. Population pharmacokinetics of gentamicin in neonates. Dev Pharmacol Ther 1988;11:173-9
Moore RD, Smith CR, Lietman PS. The association of aminoglycoside plasma levels with mortality in patients with Gram negative bacteremia. J Infect Dis 1984;149:443-8
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gooding, N., Elias‐Jones, A. & Shenoy, M. Gentamicin dosing in neonatal patients. Pharm World Sci 23, 179–180 (2001). https://doi.org/10.1023/A:1012221801816
Issue Date:
DOI: https://doi.org/10.1023/A:1012221801816